Seelos Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Seelos Therapeutics has further postponed its 2024 Annual Meeting of Stockholders to November 25, 2024, due to an anticipated lack of quorum.
OTC.Pink
DEFA14A: Seelos Therapeutics Postpones Annual Meeting of Stockholders Due to Anticipated Lack of Quorum
Seelos Therapeutics has postponed its 2024 Annual Meeting of Stockholders from September 27, 2024, to October 25, 2024, due to an anticipated lack of quorum.
OTC.Pink
Seelos Therapeutics has scheduled its annual stockholders meeting for September 27, 2024, to vote on director elections, auditor ratification, executive compensation, and proposals related to convertible notes and warrant inducements.